<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00523120</url>
  </required_header>
  <id_info>
    <org_study_id>HP 7-264S</org_study_id>
    <nct_id>NCT00523120</nct_id>
  </id_info>
  <brief_title>Topical Voltaren in Otitis Externa</brief_title>
  <official_title>Topical Voltaren as an Alternative Treatment for Otitis Externa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sieff Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sieff Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single
      drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption
      of oral analgesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      anticipated advantages are: reduction of inflammation and edema, no fungal overpopulation-
      when steroids are employed, contains boric acid as an ingredient, high safety profile, can be
      switched to antibiotic therapy later, can be used in conjunction wit steroids
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reducing oral analagestic use</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>adding an alternative treatment for otitis externa</measure>
    <time_frame>1 week</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Otitis Externa</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>voltaren ophta</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexotic</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diclofenac sodium</intervention_name>
    <description>topical solution used in ear 5 drops 8 3/day</description>
    <arm_group_label>1</arm_group_label>
    <other_name>voltaren ophta</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexotc</intervention_name>
    <description>aural drops</description>
    <arm_group_label>2</arm_group_label>
    <other_name>dexotic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults having otitis externa as single diagnosis mild to moderate

        Exclusion Criteria:

          -  Diabetes

          -  Children

          -  Pregnant women

          -  Immune compromise

          -  Starting other treatment

          -  Moderate to severe otitis externa
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>victor kizhner, m.d.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sieff Medical Center, Safed, ISRAEL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sieff Medical Center</name>
      <address>
        <city>Safed</city>
        <zip>13100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://www.ziv.org.il/</url>
    <description>Sieff Medical Center</description>
  </link>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2007</study_first_submitted>
  <study_first_submitted_qc>August 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2007</study_first_posted>
  <last_update_submitted>April 18, 2016</last_update_submitted>
  <last_update_submitted_qc>April 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sieff Medical Center</investigator_affiliation>
    <investigator_full_name>victor kizhner</investigator_full_name>
    <investigator_title>Victor Kizhner MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Externa</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

